Project 4
项目4
基本信息
- 批准号:10005308
- 负责人:
- 金额:$ 68.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-19 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdoptedAdultAffectBehaviorCartoonsCharacteristicsCigaretteDataDimensionsElderlyElectronic cigaretteEquilibriumFaceFemaleFlavoringGlycerolHealthHealth BenefitHumanImageLabelLaboratoriesLaboratory ResearchMarketingMasksMeasuresMentholMethodsNamesNicotineNicotine DependenceOutcomeOutcome MeasureParticipantPeachPharyngeal structurePopulationPopulation HeterogeneityPropylene GlycolsPsychological reinforcementRecording of previous eventsRegulationResearchResourcesRewardsRiskSamplingSelf AdministrationSensorySex DifferencesSmokerSmokingStandardizationStudy SubjectTaste PerceptionTaste preferencesTestingThickTobaccoTobacco useVariantVegetablesYouthaddictionage relatedcigarette smokecohortdesignelectronic cigarette useelectronic cigarette userelectronic liquidexperienceexperimental studyinterestmalemiddle agenever smokernever smokingpreferencesextobacco controltobacco regulatory sciencevapingvaporyoung adult
项目摘要
ABSTRACT: PROJECT 4 (P4)
Background: E-cigarettes pose a regulatory challenge because they may adversely impact the health of some
populations (e.g., young never-smokers), but reduce health risk in others (e.g., middle-aged/older smokers who
switch to e-cigarettes). P4 aims to provide FDA with evidence to inform regulatory restrictions of dimensions of
e-cigarette product diversity that put young adult never-smokers at risk of using e-cigarettes, yet does not deter
middle/older adult smokers from adopting and potentially switching to e-cigarettes. P4 will test the hypotheses
regarding how product diversity impacts the user experience—a key channel of exposure: a) Young never-smok-
ers may prefer e-liquids with sweet flavorings due to age-related taste preferences and menthol flavors that mask
the bitterness of nicotine; yet, middle-age/adult smokers may be more accustomed to tobacco flavorings, b) E-
liquid labels with cartoon images and youth-oriented product names (e.g., ‘Killer Kustard’) may appeal more to
young (vs. middle-age/older) adults. c) Low propylene glycol (PG)/vegetable glycerin (VG) ratio in e-liquids pro-
duces thick ‘vapor clouds’ and a weak throat hit, which may appeal to young adults, but middle-age/older adult
smokers may prefer vapor that resembles cigarette smoke. Method: Drawing from the USC-TCORS cohort and
Population Core resources, P4 will compare never-smoking young adult e-cigarette users to middle-age/older
adult smokers with an interest in, but no significant experience with, e-cigarettes. In two studies, subjects will
self-administer e-cigarette products systematically varied according to Flavor (sweet vs. menthol vs. tobacco) ×
PG/VG ratio (20:80 vs. 40:60 vs. 60:40 vs. 80:20) × Packaging (e-liquid characterizing flavor label [e.g., “peach”]
vs. youth-oriented non-characterizing flavor [e.g., “gummy heaven”] vs. non-characterizing flavor + cartoon) de-
sign. The Aim 1 study will test product exposure effects on subjective ratings of appeal (e.g., liking, desire to use
again). The Aim 2 study will test product exposure effects on choice to use (vs. earn money): a) The previously-
exposed e-cigarette product (an abuse liability test; never-smoking young adults only), or b) Own brand ciga-
rettes (test of ability to resist smoking; middle-age/older adult smokers only). Aim 1. Determine which dimen-
sions of e-cigarette product diversity differentially affect appeal across never-smoking young adult e-cigarette
users (N=200) and middle-age/older smokers (N=200). Aim 2. Determine which dimensions of e-cigarette prod-
uct diversity differentially affect abuse liability in never-smoking young adult e-cigarette users (N=360) and ability
to resist smoking in middle-age/older adult smokers (N=360). Integration with “Intersections of Products with
Populations” theme: P4 will study dimensions of e-cigarette product diversity common to those studied in other
USC-TCORS projects using a unique controlled experimental paradigm to inform causal mechanisms. P4 has a
secondary aim (Aim 3) that will determine how population diversity in sex alters the appeal and abuse liability of
e-cigarette products. FDA Scientific domains addressed: Addiction, Behavior, and Marketing.
摘要:项目4 (p4)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Matthew Leventhal其他文献
Adam Matthew Leventhal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Matthew Leventhal', 18)}}的其他基金
Tobacco Use Treatment Research for Vulnerable Populations
弱势群体烟草使用治疗研究
- 批准号:
9897514 - 财政年份:2019
- 资助金额:
$ 68.12万 - 项目类别:
Tobacco Use Treatment Research for Vulnerable Populations
弱势群体烟草使用治疗研究
- 批准号:
10368943 - 财政年份:2019
- 资助金额:
$ 68.12万 - 项目类别:
Tobacco Use Treatment Research for Vulnerable Populations
弱势群体烟草使用治疗研究
- 批准号:
10613438 - 财政年份:2019
- 资助金额:
$ 68.12万 - 项目类别:
Tobacco Regulatory Science Investigating the Intersections of Products with Diverse Populations
烟草监管科学调查产品与不同人群的交叉点
- 批准号:
10252828 - 财政年份:2013
- 资助金额:
$ 68.12万 - 项目类别:
Neuroendocrine Factors, Nicotine, and Behavioral Inhibition in Female Smokers
女性吸烟者的神经内分泌因素、尼古丁和行为抑制
- 批准号:
8587421 - 财政年份:2013
- 资助金额:
$ 68.12万 - 项目类别:
Neuroendocrine Factors, Nicotine, and Behavioral Inhibition in Female Smokers
女性吸烟者的神经内分泌因素、尼古丁和行为抑制
- 批准号:
8730589 - 财政年份:2013
- 资助金额:
$ 68.12万 - 项目类别:
Tobacco Regulatory Science Investigating the Intersections of Products with Diverse Populations
烟草监管科学调查产品与不同人群的交叉点
- 批准号:
10488642 - 财政年份:2013
- 资助金额:
$ 68.12万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 68.12万 - 项目类别:
Research Grant














{{item.name}}会员




